Literature DB >> 31632815

The radical approach to the oligometastatic not small cell lung cancer patient: which? how? when? where?

Luca Bertolaccini1, Lorenzo Spaggiari1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31632815      PMCID： PMC6783794          DOI： 10.21037/jtd.2019.06.28

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

1.  Commentary: Keeping surgery relevant in oligometastatic non-small cell lung cancer.

Authors:  Jessica S Donington
Journal:  J Thorac Cardiovasc Surg       Date:  2018-11-08       Impact factor: 5.209

2.  Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study.

Authors:  Oscar Arrieta; Feliciano Barrón; Federico Maldonado; Luis Cabrera; José Francisco Corona-Cruz; Monika Blake; Laura Alejandra Ramírez-Tirado; Zyanya Lucia Zatarain-Barrón; Andrés F Cardona; Osvaldo García; Osvaldo Arén; Jaime De la Garza
Journal:  Lung Cancer       Date:  2019-02-07       Impact factor: 5.705

3.  Clinical outcome of patients with recurrent non-small cell lung cancer after trimodality therapy.

Authors:  Ken Suzawa; Junichi Soh; Yuta Takahashi; Hiroki Sato; Kazuhiko Shien; Hiromasa Yamamoto; Susumu Kanazawa; Katsuyuki Kiura; Shinichiro Miyoshi; Shinichi Toyooka
Journal:  Surg Today       Date:  2019-02-08       Impact factor: 2.549

Review 4.  The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer.

Authors:  Elizabeth A David; James M Clark; David T Cooke; Joy Melnikow; Karen Kelly; Robert J Canter
Journal:  J Thorac Oncol       Date:  2017-08-24       Impact factor: 15.609

5.  Managing Patients With Oligometastatic Non-Small-Cell Lung Cancer.

Authors:  Sarah Jo Stephens; Michael J Moravan; Joseph K Salama
Journal:  J Oncol Pract       Date:  2018-01       Impact factor: 3.840

Review 6.  Surgical approach in oligometastatic non-small cell lung cancer.

Authors:  Davide Patrini; Nikolaos Panagiotopoulos; Benedetta Bedetti; Sofoklis Mitsos; Roberto Crisci; Piergiorgio Solli; Luca Bertolaccini; Marco Scarci
Journal:  Ann Transl Med       Date:  2018-03

7.  Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience.

Authors:  Maria Teresa Congedo; Alfredo Cesario; Filippo Lococo; Chiara De Waure; Giovanni Apolone; Elisa Meacci; Sergio Cavuto; Pierluigi Granone
Journal:  J Thorac Cardiovasc Surg       Date:  2012-06-17       Impact factor: 5.209

Review 8.  The current state of oligometastatic and oligoprogressive non-small cell lung cancer.

Authors:  Vasu Tumati; Puneeth Iyengar
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

9.  The 150 most important questions in cancer research and clinical oncology series: questions 40-49.

Authors: 
Journal:  Chin J Cancer       Date:  2017-07-13

Review 10.  Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence?

Authors:  Christopher M Jones; Alessandro Brunelli; Matthew E Callister; Kevin N Franks
Journal:  Curr Surg Rep       Date:  2018-02-08
View more
  1 in total

Review 1.  Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review.

Authors:  Luca Bertolaccini; Monica Casiraghi; Giulia Sedda; Filippo de Marinis; Lorenzo Spaggiari
Journal:  Transl Lung Cancer Res       Date:  2021-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.